factory supply 99% Exem'estane powder

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 25.0000 -500.0000

1 Kilogram

FOB Price:USD 25.0000 -500.0000

Min.Order :1 Kilogram
Purity: 99% up
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Exem'estane factory price High purity 99%

Quick Details

Appearance:White powder
Application: It is used for natural or artificial postmenopausal patients whose condition has not progressed after tamo xifen treatment.
PackAge:1kg/bag ;5kg/drum:25KG/drum
ProductionCapacity:20|Metric Ton|Month
Storage:in low tempreture
Transportation:in low tempreture

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier .

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Why choose us

1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin

Details:

Product Information

Product Name	Exem'estane
CAS	107868-30-4
MF	C20H24O2
MW	296.4
EINCES	643-090-2
MP	155.13°C
BP	453.7±45.0 °C(Predicted)
Density	1.13±0.1 g/cm3(Predicted)
Storage Conditions	2-8°C
Shelf life	2 Years
Delivery time	7-10 Days

Usage

xem’estane is an irreversible steroidal aromatase inhibitor with a structure similar to its substrate natural andro stenedione. Deprivation of estrogen by inhibiting aromatase is an effective and alternative method for the treatment of hormone-dependent breast cancer in postmenopausal women. It is used for natural or artificial postmenopausal patients whose condition has not progressed after tamo xifen treatment. Women's advanced breast cancer.